pI: 8.4114 |
Length (AA): 2403 |
MW (Da): 276999 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
719 | 830 | 5j0l (C) | 10 | 124 | 19.00 | 0.59 | 0.03 | 0.187708 | -0.78 |
864 | 2384 | 4i43 (B) | 885 | 2396 | 40.00 | 0 | 1 | 1.04506 | -0.03 |
1821 | 2079 | 3e9l (A) | 1760 | 2016 | 42.00 | 0 | 1 | 0.723882 | -1.07 |
1902 | 2053 | 3lru (B) | 1840 | 1990 | 43.00 | 0 | 1 | 0.327754 | 0.19 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127578)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G38780 | Pre-mRNA-processing-splicing factor |
Arabidopsis thaliana | AT1G80070 | putative splicing factor Prp8 |
Babesia bovis | BBOV_IV007790 | processing splicing factor 8, putative |
Brugia malayi | Bm1_41550 | Pre-mRNA splicing factor PRP8 |
Candida albicans | CaO19.13800 | similar to S. cerevisiae PRP8 (YHR165C) crucial component of the spliceosome and U5 snRNP |
Candida albicans | CaO19.6442 | similar to S. cerevisiae PRP8 (YHR165C) crucial component of the spliceosome and U5 snRNP |
Caenorhabditis elegans | CELE_C50C3.6 | Protein PRP-8 |
Cryptosporidium hominis | Chro.30328 | ENSANGP00000005722 |
Cryptosporidium parvum | cgd3_2890 | Prp8. JAB/PAD domain |
Dictyostelium discoideum | DDB_G0274229 | Mov34/MPN/PAD-1 domain-containing protein |
Drosophila melanogaster | Dmel_CG8877 | pre-mRNA processing factor 8 |
Echinococcus granulosus | EgrG_000151700 | pre mRNA processing splicing factor 8 |
Entamoeba histolytica | EHI_060350 | splicing factor Prp8, putative |
Echinococcus multilocularis | EmuJ_000151700 | pre mRNA processing splicing factor 8 |
Giardia lamblia | GL50803_112114 | Splicing factor-like protein, putative |
Homo sapiens | ENSG00000174231 | pre-mRNA processing factor 8 |
Leishmania braziliensis | LbrM.34.3940 | PRP8 protein homologue, putative,U5 snRNA-associated splicing factor |
Leishmania donovani | LdBPK_354000.1 | PRP8 protein homologue, putative |
Leishmania infantum | LinJ.35.4000 | PRP8 protein homologue, putative,U5 snRNA-associated splicing factor |
Leishmania major | LmjF.35.3950 | PRP8 protein homologue, putative,U5 snRNA-associated splicing factor |
Leishmania mexicana | LmxM.34.3950 | PRP8 protein homologue, putative,U5 snRNA-associated splicing factor |
Loa Loa (eye worm) | LOAG_00327 | pre-mRNA splicing factor PRP8 |
Mus musculus | ENSMUSG00000020850 | pre-mRNA processing factor 8 |
Neospora caninum | NCLIV_031970 | hypothetical protein |
Oryza sativa | 4340248 | Os06g0167000 |
Oryza sativa | 4337900 | Os05g0163200 |
Plasmodium berghei | PBANKA_1003100 | pre-mRNA-processing-splicing factor 8, putative |
Plasmodium falciparum | PF3D7_0405400 | pre-mRNA-processing-splicing factor 8, putative |
Plasmodium knowlesi | PKNH_0303500 | pre-mRNA-processing-splicing factor 8, putative |
Plasmodium vivax | PVX_000970 | pre-mRNA-processing-splicing factor 8, putative |
Plasmodium yoelii | PY01669 | hypothetical protein |
Saccharomyces cerevisiae | YHR165C | U4/U6-U5 snRNP complex component PRP8 |
Schistosoma japonicum | Sjp_0036700 | Pre-mRNA-processing-splicing factor 8, putative |
Schistosoma japonicum | Sjp_0036690 | Pre-mRNA-processing-splicing factor 8, putative |
Schistosoma mansoni | Smp_140890 | splicing factor Prp8 |
Schmidtea mediterranea | mk4.004704.01 | Putative pre-mRNA splicing factor prp8 |
Schmidtea mediterranea | mk4.002311.02 | Pre-mRNA-splicing factor 8 homolog |
Schmidtea mediterranea | mk4.002311.03 | Putative pre-mRNA splicing factor prp8 |
Schmidtea mediterranea | mk4.003896.00 | |
Schmidtea mediterranea | mk4.002311.01 | |
Schmidtea mediterranea | mk4.006236.00 | |
Schmidtea mediterranea | mk4.003280.00 | |
Schmidtea mediterranea | mk4.012505.00 | Putative pre-mRNA splicing factor prp8 |
Trypanosoma brucei gambiense | Tbg972.9.6600 | PRP8 protein homologue,U5 snRNA-associated splicing factor |
Trypanosoma brucei | Tb927.9.11110 | U5 snRNA-associated splicing factor |
Trypanosoma cruzi | TcCLB.508461.320 | U5 snRNA-associated splicing factor, putative |
Toxoplasma gondii | TGME49_231970 | pre-mRNA processing splicing factor PRP8 |
Theileria parva | TP03_0292 | splicing factor Prp8, putative |
Trichomonas vaginalis | TVAG_206870 | pre-mRNA splicing factor prp8, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.211.2420 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.2420 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.2420 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.2420 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C50C3.6 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C50C3.6 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C50C3.6 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C50C3.6 | Caenorhabditis elegans | sterile | wormbase |
YHR165C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1003100 | Plasmodium berghei | Essential | plasmo |
TGME49_231970 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.